Keyphrases
Breast Cancer
100%
Cancer-related
100%
Long-term Survival
100%
Radiological Response
100%
High-dose Methotrexate (HD-MTX)
100%
Leptomeningeal Disease
100%
Blood-brain Barrier
40%
Malignancy
40%
Methotrexate
40%
Human Epidermal Growth Factor Receptor 2 (HER2)
40%
Patient Demographics
20%
Treatment Strategy
20%
Tumor
20%
Adverse Effects
20%
Clinical Efficacy
20%
High Incidence
20%
Median Survival
20%
High Dose
20%
Poor Prognosis
20%
Trastuzumab
20%
Remission
20%
Conventional Therapy
20%
Metastasizing
20%
Invasive Procedures
20%
Radiation Therapy
20%
Central Nervous System Involvement
20%
Breast Cancer Subtypes
20%
Radiologic
20%
Conventional Treatment
20%
Rare Manifestation
20%
Disequilibrium
20%
Leptomeninges
20%
Systemic Methotrexate
20%
New-onset Headache
20%
Intravesical Chemotherapy
20%
Medicine and Dentistry
Breast Cancer
100%
Drug Megadose
100%
Long Term Survival
100%
Methotrexate
100%
Diseases
100%
Blood Brain Barrier
40%
Gamma Urogastrone
40%
Epidermal Growth Factor Receptor 2
40%
Cancer
40%
Neoplasm
20%
Prospective Study
20%
Patient Population
20%
Headache
20%
Invasive Procedure
20%
Central Nervous System
20%
Leptomeninx
20%
Intrathecal Drug Administration
20%
Adverse Effect
20%
Trastuzumab
20%
Radiation Therapy
20%